Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Buti

Showing results (251-260 of 386) with videos related to

Pageof 39
Sort By:
Scientific Reports|April 20, 2026
HCV RNA quantification using the Cobas Plasma Separation Card as an alternative to EDTA plasma: a prospective multicenter studyAna Fuentes López, Ariadna Rando Segura, Raquel Carracedo, et al.
Alimentary Pharmacology & Therapeutics|April 21, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European StudyAdriana Palom, Elisabetta Degasperi, Barbara Coco, et al.
Plos One|December 10, 2015
ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV InfectionTarik Asselah, Stefan Zeuzem, Vicente Soriano, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2024
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International NetworkAnika Wranke, Cirley Lobato, Emanoil Ceausu, et al.
Communications Medicine|December 14, 2023
Community-based screening enhances hepatitis B virus linkage to care among West African migrants in SpainCamila A Picchio, Daniel K Nomah, Ariadna Rando-Segura, et al.
Virus Evolution|May 6, 2026
Peaked-to-flat transition in quasispecies structure evolutionJosep Gregori, Sergi Colomer-Castell, Carolina Campos, et al.
The New England Journal of Medicine|August 16, 2013
Faldaprevir and deleobuvir for HCV genotype 1 infectionStefan Zeuzem, Vincent Soriano, Tarik Asselah, et al.
Hepatology (Baltimore, Md.)|May 13, 2011
Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naïve patients with a partial virological responseRoeland Zoutendijk, Jurriën G P Reijnders, Ashley Brown, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infectionNicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
World Journal of Gastroenterology|December 10, 2021
Cross-sectional evaluation of circulating hepatitis B virus RNA and DNA: Different quasispecies?Selene Garcia-Garcia, Maria Francesca Cortese, David Tabernero, et al.
Pageof 39

Showing results (251-260 of 386) with videos related to

Sort By:
Pageof 39
Scientific Reports|April 20, 2026
HCV RNA quantification using the Cobas Plasma Separation Card as an alternative to EDTA plasma: a prospective multicenter studyAna Fuentes López, Ariadna Rando Segura, Raquel Carracedo, et al.
Alimentary Pharmacology & Therapeutics|April 21, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European StudyAdriana Palom, Elisabetta Degasperi, Barbara Coco, et al.
Plos One|December 10, 2015
ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV InfectionTarik Asselah, Stefan Zeuzem, Vicente Soriano, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2024
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International NetworkAnika Wranke, Cirley Lobato, Emanoil Ceausu, et al.
Communications Medicine|December 14, 2023
Community-based screening enhances hepatitis B virus linkage to care among West African migrants in SpainCamila A Picchio, Daniel K Nomah, Ariadna Rando-Segura, et al.
Virus Evolution|May 6, 2026
Peaked-to-flat transition in quasispecies structure evolutionJosep Gregori, Sergi Colomer-Castell, Carolina Campos, et al.
The New England Journal of Medicine|August 16, 2013
Faldaprevir and deleobuvir for HCV genotype 1 infectionStefan Zeuzem, Vincent Soriano, Tarik Asselah, et al.
Hepatology (Baltimore, Md.)|May 13, 2011
Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naïve patients with a partial virological responseRoeland Zoutendijk, Jurriën G P Reijnders, Ashley Brown, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infectionNicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
World Journal of Gastroenterology|December 10, 2021
Cross-sectional evaluation of circulating hepatitis B virus RNA and DNA: Different quasispecies?Selene Garcia-Garcia, Maria Francesca Cortese, David Tabernero, et al.
Pageof 39